# Patricia Van der Niepen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patricia-van-der-niepen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,170 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 29 |
| i10-index | 49 |
| Last Known Institution | Vrije Universiteit Brussel |
| OpenAlex ID | https://openalex.org/A5047871584 |
| ORCID iD | 0000-0002-6401-1580 |
| Works | 180 |

## Researcher papers

- [Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension](https://scholariq.org/papers/prognostic-value-of-ambulatory-blood-pressure-recordings-in-patients-with/)
- [First International Consensus on the diagnosis and management of fibromuscular dysplasia](https://scholariq.org/papers/first-international-consensus-on-the-diagnosis-and-management-of-fibromuscular/)
- [Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial](https://scholariq.org/papers/intermittent-versus-continuous-renal-replacement-therapy-for-acute-kidney-injury/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury](https://scholariq.org/papers/renal-replacement-therapy-is-an-independent-risk-factor-for-mortality-in/)
- [Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review](https://scholariq.org/papers/renal-blood-oxygenation-level-dependent-magnetic-resonance-imaging-to-measure/)
- [First international consensus on the diagnosis and management of fibromuscular dysplasia](https://scholariq.org/papers/first-international-consensus-on-the-diagnosis-and-management-of-fibromuscular-2/)
- [Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients](https://scholariq.org/papers/treatment-with-recombinant-human-erythropoietin-increases-antibody-titers-after/)
- [Hypertension in dialysis patients](https://scholariq.org/papers/hypertension-in-dialysis-patients/)
- [The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)—clinical phenotypes and their predictors based on a cohort of 1000 patients](https://scholariq.org/papers/the-european-international-fibromuscular-dysplasia-registry-and-initiative-feiri/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Abdominal vascular conditions and treatments](https://scholariq.org/topics/abdominal-vascular-conditions-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

## Researcher university

- [Vrije Universiteit Brussel](https://scholariq.org/institutions/vrije-universiteit-brussel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.